Next Article in Journal
Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation
Next Article in Special Issue
Human Aquaporin 4 Gating Dynamics under Perpendicularly-Oriented Electric-Field Impulses: A Molecular Dynamics Study
Previous Article in Journal
Interspecies and Intraspecies Analysis of Trehalose Contents and the Biosynthesis Pathway Gene Family Reveals Crucial Roles of Trehalose in Osmotic-Stress Tolerance in Cassava
Previous Article in Special Issue
Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 17
Issue 7
10.3390/ijms17071121
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Astrocyte Aquaporin Dynamics in Health and Disease

by
Maja Potokar
1,2,†,
Jernej Jorgačevski
1,2,† and
Robert Zorec
1,2,*
1
Laboratory of Neuroendocrinology—Molecular Cell Physiology, Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Zaloška 4, 1000 Ljubljana, Slovenia
2
Celica Biomedical, Tehnološki Park 24, 1000 Ljubljana, Slovenia
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2016, 17(7), 1121; https://doi.org/10.3390/ijms17071121
Submission received: 26 May 2016 / Revised: 7 July 2016 / Accepted: 7 July 2016 / Published: 13 July 2016
(This article belongs to the Special Issue Aquaporin)
Browse Figures
Versions Notes

Abstract

:
The family of aquaporins (AQPs), membrane water channels, consists of diverse types of proteins that are mainly permeable to water; some are also permeable to small solutes, such as glycerol and urea. They have been identified in a wide range of organisms, from microbes to vertebrates and plants, and are expressed in various tissues. Here, we focus on AQP types and their isoforms in astrocytes, a major glial cell type in the central nervous system (CNS). Astrocytes have anatomical contact with the microvasculature, pia, and neurons. Of the many roles that astrocytes have in the CNS, they are key in maintaining water homeostasis. The processes involved in this regulation have been investigated intensively, in particular regulation of the permeability and expression patterns of different AQP types in astrocytes. Three aquaporin types have been described in astrocytes: aquaporins AQP1 and AQP4 and aquaglyceroporin AQP9. The aim here is to review their isoforms, subcellular localization, permeability regulation, and expression patterns in the CNS. In the human CNS, AQP4 is expressed in normal physiological and pathological conditions, but astrocytic expression of AQP1 and AQP9 is mainly associated with a pathological state.

Graphical Abstract

1. Water Homeostasis, Brain Edema, and Astrocytes

Water homeostasis in the central nervous system (CNS) is tightly regulated, as even minute changes in extracellular volume affect ion concentrations and, consequently, neuronal excitability [1]. Dysregulated distribution of water in the neural tissue often occurs in brain tumors, brain abscess, meningitis, stroke, and neurotrauma, when brain edema forms and often worsens the outcome of these disorders [2,3]. As the brain is encapsulated within the cranium, it has very limited space for volume enlargement during brain edema. Therefore, mechanisms for efficient and quick redistribution of water within the brain parenchyma are essential for normal neuronal function. Such mechanisms are still largely unclear and, therefore, the possibilities for medical intervention when brain edema develops are limited. Vasogenic edema, which is amenable to treatment, results mainly from increased permeability of the blood–brain barrier [4], whereas cytotoxic edema results from cellular swelling, mainly caused by failure of energy metabolism [3]. Although cell swelling can be, at least in part, attenuated by adrenergic stimulation [5], currently there appears to be no efficient treatment for this event.
Astrocytes are the only cells in the CNS that undergo rapid changes in volume [6,7,8]. These cells populate the gray and white matter of the CNS and are, arguably, the most heterogeneous (in form and function) type of glia [9,10]. Astrocytes can be broadly defined as primary homeostatic cells of the brain responsible for a wide variety of functions that include, for example, regulation of synaptogenesis, synaptic maturation, neurotransmitter homeostasis, brain microcirculation, brain metabolism, and control over the formation and maintenance of the blood–brain barrier [8,11,12,13,14,15,16,17,18,19,20,21,22,23]. All of these processes depend, to a large extent, on the mechanisms by which astrocytes communicate with the surrounding cells. These include plasma membrane channels, receptors, transporters, and mechanisms that mediate the exchange of molecules by exo- and endocytotic processes [24,25,26,27,28,29,30]. Exo- and endocytotic processes involve vesicles, from which signaling molecules are released in the extracellular space, or membrane channels, such as aquaporins (AQPs), that are integrated in the plasma membrane. Both exo- and endocytotic vesicles are mobile in the cytoplasm [31,32] and their mobility is altered under pathologic conditions [33,34].
Non-neuronal cells, which include astrocytes, outnumber neurons in some areas in the CNS, such as the neocortex [35]. Astrocytic abundance in these areas and their anatomical occupancy of non-overlapping territories between other glial cells, neurons, and endothelial cells of the vasculature [11,13,14,15,36,37], places them ideally to enhance transport of molecules across the brain parenchyma, including the transport of water. In addition to extensive research on astrocytes in several fields, such as ion and pH homeostasis, metabolic support to neurons, and modulation of synaptic strength, their role in the regulation of brain water homeostasis is also a topic of interest. Namely, in astrocytes, specialized membrane proteins have been identified that allow fast transmembrane flux of water [38,39,40].

2. Aquaporin Types and Their Isoforms in Astrocytes

AQPs have been identified in multiple mammalian tissues as well as in invertebrates, plants, and microbes [41]. As their name suggests, APQs are proteins that are specialized in water transport across the plasma membrane of cells, although they are also involved in several other functions [39]. The plasma membrane, per se, is permeable to water molecules, which pass between the intracellular and extracellular space. However, such passive transport is slow, highlighting the need for specialized transmembrane water channels, AQPs, which allow several orders of magnitude higher rates of facilitated transmembrane water flux in the direction of greater osmolality. All AQPs are small hydrophobic proteins, composed of six non-polar bilayer-spanning domains, interconnected by loops A to E (this general description of AQPs structure is evident in the schematic representation of AQP4 depicted in the Figure 1). According to the hourglass model, the conserved loops B and E are essential for the water pore [39,42,43,44]. To date, 13 AQP types have been characterized in mammalian cells; three types, AQP1, AQP4, and AQP9, have been confirmed in the CNS [45]. They differ in their permeability properties (Table 1) and have different distribution patterns. AQP1 and AQP4 are categorized as “pure” aquaporins, water channels primarily only permeable to water, whereas AQP9 is an aquaglyceroporin, permeable to water and to small solutes, such as glycerol and urea [45]. AQP1 was the first AQP discovered in the CNS, identified in the epithelium of the choroid plexus and later also in human astrocytes [46,47]. The most abundant AQP in the mammalian brain is AQP4, which is predominantly localized in astrocytes that are in direct contact with capillaries and pia. AQP4 is not confined solely to astrocytes; it has also been found in subpopulations of ependymal cells [40]. The distribution of AQP9 in the brain is unique; it has been identified in ependymal cells lining the ventricles and in tanycytes of the mediobasal hypothalamus. AQP9 is also present in astrocytes, in endothelial cells of pial vessels, and almost exclusively in catecholaminergic neurons [48,49,50].
The strategic anatomical position of astrocytes with regard to water transport is, therefore, mirrored in the fact that all three CNS AQPs are expressed in these cells. We review these AQP types and their isoforms in respect of their expression patterns, intracellular localization, permeability regulation, and their role in normal physiological and pathological conditions.

2.1. Aquaporin 1

2.1.1. Aquaporin 1 (AQP1) in the Central Nervous System (CNS): Expression in Physiological and Pathological Conditions

The AQP1 channel is primarily a water pore to facilitate transmembrane transport of water molecules driven by osmotic gradients [51]. AQP1 was the first AQP to be identified, initially found in erythrocytes and renal tubules [38,52,53,54]. Its expression was also confirmed in other tissues as shown in Table 2. In the CNS, AQP1 was first detected in rat choroid plexus epithelial cells where it is restricted to their apical microvilli [55]. Its distribution in the choroid plexus epithelium (CPE) implied a role in the secretion of cerebrospinal fluid (CSF) into ventricles, which was subsequently confirmed [51,55,56,57,58].
In addition to the CPE, the expression of AQP1 was also confirmed in CNS astrocytes. However, in human astrocytes, its expression is mainly restricted to neuropathologic conditions, e.g., multiple sclerosis (MS), Alzheimer disease (AD), Parkinson disease (PD), and amyotrophic lateral sclerosis [47,62,65]. AQP1 in astrocytes has been detected in astrocytomas in subarachnoid hemorrhage tissue, in Creutzfeldt–Jakob disease (CJD), in bovine and murine spongiform encephalopathy, and in a rat epilepsy model [66,67,68,69,70]. Initially, no AQP1 was found in the healthy human neocortex [66], but it was later reported that a minor population of astrocytes expresses AQP1 in a neurologically normal brain [47].
In human astrocytes, the expression of AQP1 is almost exclusively restricted to pathologic CNS tissue, but it has been detected in a healthy non-human primate brain of the Macaca fascicularis monkey [63]. Therefore, in at least some primates, astrocytic AQP1 plays an important role in the regulation of water homeostasis in the CNS in non-pathological brain. This role remains to be further elucidated.
What do we know about the intracellular distribution of AQP1 in astrocytes? In cultured human astrocytes, AQP1 was found co-expressed with AQP4 [47]. The detailed intracellular distribution of AQP1 remains to be thoroughly addressed, but it appears that its localization in cultured astrocytes is not exclusive to the plasma membrane; it is also present in the cytoplasm and likely in the nuclear membrane [47,69]. Its abundant intra-astrocyte distribution in cultured cells may be, in part, the consequence of the in vitro conditions, which differ from those in intact tissue, as was observed also for AQP4 [71,72].
However, variable intracellular distribution in astrocytomas has also been described. In low-grade astrocytomas, AQP1 immunoreactivity was present mostly in the plasma membrane, whereas in high-grade astrocytomas, massively-upregulated AQP1 was also distributed throughout the cytoplasm [70]. In addition to the variable intra-astrocytic distribution of AQP1, the expression of AQP1 also varies among different types of astrocytes, as was shown in intact CNS tissue. High expression of AQP1 was detected in highly-branched fibrillary astrocytes, whereas expression was low in poorly-branched protoplasmic and hypertrophic astrocytes. For example, this pattern was observed in MS and AD brain [47,62]. In both cases, AQP1 expression was observed in highly-branched fibrillary astrocytes positioned around blood vessels and neurons in tissue showing degenerative changes. In the MS brain, such astrocytes were present in chronic active demyelinating lesions and in the AD brain, they were in close proximity to β-amyloid plaques. Reactive astrocytes in pathological brain parenchyma can express AQP1, AQP4, or both, as was demonstrated in the tissue section of the motor cortex in a patient with PD [62]. In addition, in AD brain, increased expression of AQP1 in astrocytes has been observed only in the early stages of AD [65,69]. Therefore, the expression of AQP1 in human pathological CNS astrocytes appears to be spatially and temporally regulated.
The upregulation of AQP1 may have a pivotal role in the maintenance of water homeostasis in the CNS under pathologic conditions; however, detailed mechanisms remain to be elucidated [70].

2.1.2. Water Permeability of AQP1

Most of the data on the regulation of AQP1 water permeability comes from studies on Xenopus oocytes; AQP1 regulation in astrocytes remains to be determined. In general, water permeability through AQP1 may be regulated at several levels. One of them is phosphorylation. AQP1 has four potential phosphorylation sites that can be phosphorylated by protein kinase A (PKA), protein kinase C (PKC), and calmodulin-dependent kinase II (CKII). These phosphorylation sites are conserved in humans, rats, and mice [73]. Several contradictory results have been reported regarding the effect of AQP1 phosphorylation on water permeability in Xenopus oocytes. Phosphorylation of AQP1 by PKA and PKC was reported to increase water channel permeability in Xenopus oocytes [74,75], but others reported that phosphorylation by PKA or PKC did not affect water permeability of aquaporins 1–5 [76]. In addition to kinases, atrial natriuretic peptide (ANP) and arginine vasopressin (AVP) have also been shown to modulate water permeability of AQP1 in transfected Xenopus oocytes. AVP has been shown to increase and ANP to decrease membrane water permeability [77].
Water permeability of AQP1-expressing cells may also be related to AQP1 redistribution to the plasma membrane. Such cAMP-dependent redistribution of AQP1 has been demonstrated in Xenopus oocytes [74]. Similarly, in rat cholangiocytes, increased insertion of AQP1 in the apical membrane triggered by microtubule-dependent secretin was observed [78]. In addition to short-term regulation, long-term regulation of AQP1 water permeability is also important [73]. Both aspects of regulation in astrocytes are still unclear.

2.2. Aquaporin 4

2.2.1. AQP4 in the CNS: Expression in Physiological Conditions

AQP4 was first cloned from rat lung and then identified in different tissues (Table 3) [79,80]. It is predominantly expressed in the brain, where it is also the most abundant water channel [39,40,42]. A subpopulation of ependymal cells lining the ventricles also expresses AQP4, but the principal site of AQP4 expression in the CNS is astrocytes [40,80,81,82]. The highest levels of AQP4 expression were recorded in astrocytes along the subarachnoid space, ventricles, blood vessels, and in areas for osmosensation and regulation of body water balance, including the supraoptic nucleus and subfornical organ [40]. Particularly enriched expression of AQP4 occurs in astrocytes in contact with capillaries and pia, indicating that this AQP4 expression is associated with brain–blood or brain–liquor interfaces [40,63]. In addition, AQP4 is also found on astrocytic processes around synapses. Astrocytes enwrapping distinct types of synapses express different amounts of AQP4, i.e., strong immunoreactivity was found in the glial processes in contact with parallel fiber synapses on Purkinje cell dendritic spines, whereas in other synapses astrocyte processes were modestly labeled [40,83,84].

2.2.2. Intracellular Distribution of AQP4

In general, the intracellular distribution of AQP4 in astrocytes is distinctly polarized, predominantly concentrated in the plasma membrane of glial processes close to or in direct contact with blood vessels, the ependymal layer, and pia [40,85]. However, in distinct osmosensory areas, glial processes show little or no polarization of AQP4 distribution [40]. A similar observation was described for rat and mouse astrocyte cultures, where immunolabeling of AQP4 revealed an intracellular and plasma membrane pattern [71,72]. The strong intracellular pattern observed in cultured murine astrocytes may also be a consequence of the extracellular milieu that is altered in comparison with that in intact tissue. By different experimental manipulation, localization of AQP4 in the plasma membrane significantly increased in stellation-induced rat astrocytes [71] and in astrocytes plated on a basement membrane matrix consisting mainly of laminin [72].
Several AQP4 isoforms are recognized in astrocytes (AQP4a–f; Table 4), but the description of AQP4 intracellular distribution is more complex [42,89,90]. The intracellular localization of individual AQP4 isoforms is well described for the two most studied isoforms, AQP4a (M1) and AQP4c (M23), but it is still poorly investigated for other isoforms. Briefly, to date, seven isoforms of AQP4 water channel have been described; AQP4a–f, which were all detected in astrocytes, and AQP4-Δ [89,91]. The first two AQP4 isoforms to be described in humans, rats, and mice are AQP4a (M1) and AQP4c (M23), which are alternative transcripts from two different initiating methionine sites [42,79,90,92,93]. In rat CNS, the shorter AQP4c (M23; 32 kDa) isoform was shown to be more abundant than the longer AQP4a (M1; 34 kDa) isoform [90,94].
A thorough mapping of the rat AQP4 gene revealed four additional isoforms besides the two classic isoforms: AQP4a (M1) and AQP4c (M23) [89]. Hence, a new uniform terminology was proposed. M1 and M23 were renamed as AQP4a and AQP4c, respectively, and additional isoforms were named AQP4b, AQP4d, AQP4e (also termed Mz isoform [96]), and AQP4f [89]. The AQP4e-sized (36 kDa) isoform was later confirmed in mice, pigs, and humans [97]. Plasma membrane water-permeable isoforms AQP4a, AQP4c, and AQP4e are basic isoforms, whereas AQP4b, AQP4d, and AQP4f are their alternative splicing variants [89]. The latter three isoforms have so far been shown to be intracellular, and, based on their structure, it is hypothesized that they are unlikely to transport water. All three isoforms lack exon 2, which is why they have only four transmembrane helices; the other three isoforms all have all six (Figure 1). They lack helices 4 and 5 together with their interconnecting loop D, which is one of the stabilizing factors of AQP4. When transfected into Xenopus oocytes, they failed to enhance water permeability through their plasma membrane [89]. However, this is not entirely surprising, given their likely intracellular localization.
Different AQP4 isoforms have distinct localization at the subcellular level. AQP4a (M1) and AQP4c (M23) are predominantly localized at the plasma membrane of perivascular endfeet regions of astrocytes. Although, in addition to their strong distribution in the plasma membrane, intracellular localization was also observed in cultured astrocytes [85,90,95]. Localization of AQP4e in the plasma membrane has already been confirmed in rat brain lysates, Xenopus oocytes, HeLa cell lines, human malignant glioblastoma cell lines, and in primary cultured rat astrocytes [72,89,96,98]. The abundance of its expression in the plasma membrane of astrocytes appears to be dynamic, affected by the osmolality of the extracellular milieu [72]. In addition to the plasma membrane, internal AQP4e localization has also been observed in HeLa cell lines, as well as cultured rat astrocytes, consistent with the recycling of AQP4 [72,89,99]. Intracellularly, the AQP4e isoform was found in the Golgi apparatus (GA) and in late endosomal degradation compartments [72]. Moreover, it was also observed in highly dynamic vesicles, the mobility of which was impaired in a model of reactive gliosis and at high levels of intracellular concentration of calcium ions. In hypo-osmotic conditions, mimicking cell edema, the mobility of vesicles carrying the AQP4e isoform changed in different intervals after hypo-osmotic stimulation and was inversely correlated with the abundance of AQP4 at the plasma membrane. Decreased mobility overlapped with increased plasma membrane localization [72].
AQP4b, AQP4d, and AQP4f isoforms remained situated intracellularly when expressed in Xenopus oocytes and in HeLa cells and all of them were shown to colocalize with GA and showed a broader cytoplasmic distribution [89]. In cultured astrocytes, AQP4d was also detected intracellularly in GA and in late endosomal degradation compartments [72]. To understand the role of the intracellular AQP4 isoforms in astrocytes, especially those newly detected, there is a need to systematically investigate their subcellular localization and function.
In addition to AQP4b, AQP4d, and AQP4f, another intracellular AQP4 isoform was described in skeletal muscle. This is alternatively spliced transcript named AQP4-Δ4 that lacks exon 4. AQP4-Δ4 lacks the final part of transmembrane helix 5 and loop E, which contains the second asparagine-proline-alanine (NPA) motif essential for the formation of the structural domain for water permeation in the aquaporin monomeric channel (Figure 1). NPA motifs form the loops connecting helices 2 and 3, and 5 and 6, on the opposite sides of the membrane bilayer [42,91,100,101]. AQP4-Δ4 shows no water transport properties in HeLa cells and was shown to reside in the ER, although a minor amount of AQP4-Δ4 was detected at the plasma membrane. AQP4-Δ4 was proposed to downregulate the expression and activity of AQP4, which likely originates from a dominant-negative effect caused by heterodimerization between AQP4 and AQP4-Δ4 [91]. Similar to the intracellular AQP4 isoforms, several other aquaporins are localized in intracellular membrane compartments, such as AQP2, AQP6, AQP8, AQP10, and AQP11 [102,103,104,105,106,107].

2.2.3. Orthogonal Arrays of Particles

A unique property of the AQP4 water channel is the formation of higher-order structures in the plasma membrane. First, monomers assemble into tetramers, which then aggregate into larger structures called orthogonal arrays of particles (OAPs) [108]. OAPs have been identified in several mammalian tissues and have been named in line with their appearance (orthogonal lattices) when visualized by freeze-fracture electron microscopy [109]. OAPs of AQP4 have been observed in astrocytes, trachea, sarcolemma, gastric parietal cells, kidney principal cells, ciliary body, and the intestine [80]. In the CNS, extensive OAPs are found in perivascular astrocyte endfeet and in astrocyte processes of the glia limitans beneath the pia [85,94,110]. Here, AQP4 tetramers (4–6 nm in size) are mostly (>90%) present as OAPs [94]. OAPs in astrocytes are formed from at least two AQP4 isoforms, AQP4a (M1) and AQP4c (M23). Although AQP4c (M23) has the intrinsic ability to form OAPs alone through specific intermolecular N terminus interactions, AQP4a (M1) can form OAPs only when expressed together with AQP4c (M23). OAPs assembled from AQP4a and AQP4c together are smaller than OAPs composed of AQP4c alone, showing that these two isoforms have opposing effects on OAP size [94,110,111,112,113].
In addition to AQP4a (M1) and AQP4c (M23), the AQP4e (Mz) isoform has also been proposed to assemble into OAPs, but only together with AQP4c (M23), similar to the AQP4a (M1) isoform [96,98]. There is a possibility that, in the tissue, OAPs contain all three plasma membrane water permeant isoforms, AQP4a (M1), AQP4c (M23), and AQP4e (Mz), as observed in brain lysates and in the transfected U87MG (human glioblastoma-astrocytoma) cell line [96,98]. The properties of AQP4e assembly into OAPs and the function of AQP4e in OAPs remain to be established, as well as the role of OAPs themselves. Several hypotheses have been proposed regarding the role of OAPs, including acceleration of water transport across the astrocyte plasma membrane, adhesive functions, clearance of macromolecules from brain interstitium, and optimizing gas exchange between blood and the brain [108,114,115]. However, none of these roles has been unequivocally confirmed.

2.2.4. AQP4 Water Permeability Regulation in Astrocytes

Knowledge on the water permeability of AQP4 in astrocytes is scarce. In general, it is hypothesized that water permeability through AQP4 channels can be regulated at several levels. In brief, these are phosphorylation of the channel, expression and density of AQP4 channels at the plasma membrane, the rate of AQP4-laden vesicle delivery to the plasma membrane, and aggregation of AQP4 into OAPs.
AQP4 has several potential phosphorylation sites [73], which makes the regulation of water permeability by phosphorylation plausible. However, in cultured rat astrocytes, AQP4 failed to be phosphorylated by PKA and not all of the phosphorylation sites affect water permeability, as was shown in the case of Ser111 [71,116,117]. On the other hand, activation of PKC has been shown to phosphorylate Ser180 of AQP4, which resulted in reduced water permeability and inhibition of cell migration in a glioma cell line [118]. In cultured rat astrocytes, PKC also decreased AQP4 mRNA and protein expression, probably through signal transduction [119].
Another factor that can affect water permeability through AQP4 in astrocytes is the abundance of AQP4 expression at the plasma membrane. Fast changes in the expression of AQP4 in the plasma membrane can be regulated by translocation of the channel to/from the plasma membrane via membrane-bound vesicles of the existing cellular AQP4 pool [72]. However, the possible redistribution of the AQP4 channel to/from or inside the plasma membrane has not been addressed in the tissue, where most of the AQP4 signal is observed at the plasma membrane. Changes in the expression levels of AQP4 in the plasma membrane were observed under several pathological conditions. These changes may in part involve deregulation in vesicle traffic, as in astrocytes from an AD mouse model [120]. Altered expression levels of AQP4 in pathological conditions are reviewed in detail in the following section.
It is also hypothesized that the formation of OAPs in the plasma membrane can affect water permeability of the astrocyte plasma membrane. This could be achieved through differential assembly of OAPs in a post-Golgi phase governed by different expression levels of the isoforms that are also tissue specific [94,115,121,122,123,124]. In addition, other factors regulating short-term OAP assembly/modifications need to be addressed.

2.2.5. Altered Expression of Astrocytic AQP4 in Pathologic Conditions

Under several pathologic conditions, alterations in the subcellular distribution of AQP4 and its expression levels have been reported in astrocytes. The abundance of AQP4 in the plasma membrane has been observed to either decrease or increase, and it may be linked to altered expression of the AQP4 gene or to complementary proteins. For example, an extensive decrease in the abundance of AQP4 channels in the plasma membrane was detected in the perivascular plasma membrane of astrocytes in the hippocampal area of patients with epilepsy. This decrease was attributed to decreased expression of the AQP4 anchoring protein, even though AQP4 mRNA expression increased in the same reactivated astrocytes [125,126]. Apparent discrepancies have been noted in several reports on AQP4 expression in the plasma membrane of patients with AD. The reasons for the observed decreases or increases in AQP4 in the plasma membrane remain to be clarified; however, they may arise due to samples from different stages of the disease and from different brain regions. Nonetheless, increased expression of AQP4 was observed in patients with AD with or without cerebral amyloid angiopathy (CAA), where extensive AQP4 immunoreactivity was seen around blood vessels in the CSF and brain interfaces [127]. Similarly, increased AQP4 expression was detected in cortical sections of temporal lobes of patients with AD, where AQP4 immunostaining was more intense around larger vessels or capillaries affected by CAA and it varied depending on the severity of CAA. Increased AQP4 expression was detected around senile plaques, where it was increased during early β-amyloid (Aβ) peptide deposits and was downregulated in the later stage of Aβ plaque formation [128]. On the other hand, no differences in the level of AQP4 expression were reported after Western blotting of the frontal cortex samples from patients with AD, although glial fibrillary acidic protein labeling revealed moderate astrogliosis [65,69]. Changes in the expression of AQP4 in the plasma membrane was also screened in a mouse model of AD, where an increased concentration of AQP4 was observed in astrocytic processes in synaptic regions and a decrease in AQP4 abundance in astrocyte endfeet membranes, specifically at sites of perivascular Aβ deposits [129]. Increased expression levels of AQP4 were also reported in the brain of patients with CJD, in particular in the cytoplasm of protoplasmic and fibrillary astrocytes in the cerebral cortex and white matter, respectively [69]. AQP4 immunoreactivity in astrocytes was also more abundant in brain from patients with MS, especially at the periphery of plaques [130].
In addition to neurodegenerative diseases, astrocytic AQP4 expression was upregulated in human tissue in several other pathologic conditions, such as edematous brain tumors and surrounding tissue, after subarachnoid hemorrhage, and in peritumoral tissue and ischemia [66,131,132]. The expression of AQP4 was increased in the astrocytic processes, but in certain examples, polarization on astrocytic endfeet was lost [66].
Taken together, an extensive decrease of AQP4 expression in epilepsy patients likely results in perturbed water and ion homeostasis, leading to an increased propensity for seizures and cognitive decline [129]. Upregulated plasma membrane expression of AQP4 is hypothesized to facilitate the transport of water through blood vessel walls, as well as pial and ependymal surface of the brain and contribute to the development of brain edema [125,126].

2.3. Aquaglyceroporin 9

2.3.1. AQP9 in the CNS: Expression in Physiological Conditions

AQP9 is an aquaglyceroporin and is the least studied AQP in astrocytes. Like all aquaporins, it is permeable to water but also to small solutes. When expressed in Xenopus oocytes, human AQP9 was found to be permeable to a variety of structurally-unrelated solutes, including polyols (glycerol, mannitol, sorbitol), purines (adenine), pyrimidines (uracil and the chemotherapeutic agent 5-fluorouracil), and urea analogs (thiourea) [133,134,135]. In general, the expression of AQP9 has been identified in different cell types, including astrocytes (Table 5).
In mouse brain astrocytes, expression of AQP9 was observed in the processes bordering the subarachnoid space and ventricles, in the white matter, hippocampus, hypothalamus, and lateral septum [48]. In addition, in the adult rat brain, astrocytes expressing AQP9 were detected in the white matter and gray matter [49]. AQP9 was also detected in the astrocytes of a non-human primate brain [63]. As in rodent species, AQP9 mRNA and protein were detected in other CNS cells [63]. Reports of human expression of AQP9 are scarce and are limited mainly to pathological tissue, such as astrocytomas [136,137].

2.3.2. Intracellular Distribution of AQP9

Several AQP9 isoforms have been identified to date. For example, in astrocytes and in a subpopulation of neurons (dopaminergic neurons in the substantia nigra and ventral tegmental area) isolated from rat brain, two AQP9 isoforms have been identified: ~25 and ~30 kDa isoforms. The ~30 kDa isoform is expressed in the plasma membrane and may correspond to the liver isoform (~32 kDa) or is possibly even a splicing variant. On the other hand, the ~25 kDa isoform (obtained by alternative splicing) is expressed in mitochondria and is highly enriched in the inner mitochondrial membrane of astrocytes. Its major role could be the transport of lactic acid into the mitochondria, which would benefit cells in ischemic conditions [140].
In general, AQP9 immunostaining in astrocytes was observed in their cell bodies, in processes directed toward blood vessels, and in perivascular endfeet; so it differs from AQP4 polarized immunolabeling [49,63]. In contrast, AQP9 forms only tetramers in cellular membranes and not higher-order complexes like AQP4 [98].

2.3.3. The Role of AQP9 in the CNS

Several functions of AQP9 in the CNS have been considered. AQP9 permeability to diverse molecules implies its role in diverse processes, such as water homeostasis and energy metabolism. Among several hypotheses, it was suggested that AQP9 may facilitate clearance of lactate and glycerol from the extracellular space, as is the case in cerebral ischemia [48]. Given that it is localized in the glia limitans and tanycytes, it may also contribute to water flow in CSF between the brain parenchyma and subarachnoid space [49]. Considering that AQP9 facilitates glycerol diffusion, as reported recently, it is probably also involved in energy metabolism in the CNS. Silencing of AQP9 in cultured astrocytes induced a decrease in glycerol uptake and triggered changes in astrocyte energy metabolism by increasing the glucose uptake [141]. Further investigation is needed to elucidate the processes regulated by AQP9 in the CNS in detail.

2.3.4. Permeability Regulation and Expression of AQP9 in Pathological Conditions

As in the case of AQP1 and AQP4, AQP9 can be regulated through phosphorylation, although only a few studies have investigated this. Experiments in cultured rat astrocytes suggest that signal transduction via PKC may decrease plasma membrane expression of AQP9 through PKC activation, and increase expression of AQP9 through the PKA-dependent increase of dbcAMP [116,119].
In addition, rendered plasma membrane expression of AQP9 was reported to be influenced by changes in mRNA expression. For example, an increase in mRNA and protein expression of AQP9 has been measured in human astrocytic tumors (reaching higher values in high-grade tumors) compared with normal brain tissue [136]. Overexpression of AQP9 was also detected in mouse astrocytes in peri-infarct areas after focal transient ischemia [48].
Short- and long-term permeability regulation of AQP9 in astrocytes remains to be elucidated.
Changes in the permeability regulation and expression of AQP9 are hypothesized to play a role in the regulation of postischemia edema and in the clearance of lactate from the damaged tissue, as well as in the malignant progression of brain astrocytic tumors [48,130].

3. Conclusions

Three different AQP types have been identified in astrocytes. The most abundant among them is AQP4, which is also the most studied AQP type in the brain. Its expression has been confirmed in human and non-human mammalian brain astrocytes in physiological and pathological conditions. Despite its recognized general role in the regulation of brain water homeostasis, several issues remain to be elucidated, especially in light of newly-described isoforms, their roles, and permeability regulation. In addition to water permeability through the plasma membrane, AQP4 may be implicated in various other roles, such as cell adhesion, gas exchange, and possibly other roles, especially if we consider the growing body of data on different isoforms. Although AQP1 and AQP9 are expressed in physiologically normal tissue of non-human mammalian brains, it appears that, in human astrocytes, they are expressed mainly in pathological conditions. AQP9 is the least studied of all AQP types in astrocytes; its localization in human brain has been unambiguously confirmed only in astrocytomas so far. Variations in astrocytic expression patterns of different AQP types and their permeability properties suggest that they have different roles in maintaining brain homeostasis that need to be elucidated from the perspective of efficient pharmacological manipulation.

Acknowledgments

This work was supported by the Slovenian Research Agency; grant numbers P3 310, J3 3632, J3 4051, J3-4146, J3 6790, J3 7605.

Author Contributions

Maja Potokar and Jernej Jorgačevski wrote the manuscript. Robert Zorec wrote and critically evaluated the manuscript. All authors read and approved the final manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

AQPaquaporin
OAPorthogonal array of particles
CNScentral nervous system
CPEchoroid plexus epithelium
CSFcerebrospinal fluid
MSmultiple sclerosis
ADAlzheimer disease
PDParkinson disease
CJDCreutzfeldt–Jakob disease
CAAcerebral amyloid angiopathy
PKAprotein kinase A
PKCprotein kinase C

References

  1. Amiry-Moghaddam, M.; Ottersen, O.P. The molecular basis of water transport in the brain. Nat. Rev. Neurosci. 2003, 4, 991–1001. [Google Scholar] [CrossRef] [PubMed]
  2. Saadoun, S.; Papadopoulos, M.C. Aquaporin-4 in brain and spinal cord oedema. Neuroscience 2010, 168, 1036–1046. [Google Scholar] [CrossRef] [PubMed]
  3. Stokum, J.A.; Gerzanich, V.; Simard, J.M. Molecular pathophysiology of cerebral edema. J. Cereb. Blood Flow Metab. 2016, 36, 513–538. [Google Scholar] [CrossRef] [PubMed]
  4. Harukuni, I.; Kirsch, J.R.; Bhardwaj, A. Cerebral resuscitation: Role of osmotherapy. J. Anesth. 2002, 16, 229–237. [Google Scholar] [CrossRef] [PubMed]
  5. Vardjan, N.; Horvat, A.; Anderson, J.E.; Yu, D.; Croom, D.; Zeng, X.; Luznik, Z.; Kreft, M.; Teng, Y.D.; Kirov, S.A.; et al. Adrenergic activation attenuates astrocyte swelling induced by hypotonicity and neurotrauma. Glia 2016, 64, 1034–1049. [Google Scholar] [CrossRef] [PubMed]
  6. Pangrsic, T.; Potokar, M.; Haydon, P.; Zorec, R.; Kreft, M. Astrocyte swelling leads to membrane unfolding, not membrane insertion. J. Neurochem. 2006, 99, 514–523. [Google Scholar] [CrossRef] [PubMed]
  7. Thrane, A.S.; Rappold, P.M.; Fujita, T.; Torres, A.; Bekar, L.K.; Takano, T.; Peng, W.; Wang, F.; Thrane, V.R.; Enger, R.; et al. Critical role of aquaporin-4 (AQP4) in astrocytic Ca2+ signaling events elicited by cerebral edema. Proc. Natl. Acad. Sci. USA 2011, 108, 846–851. [Google Scholar] [CrossRef] [PubMed]
  8. Risher, W.C.; Andrew, R.D.; Kirov, S.A. Real-time passive volume responses of astrocytes to acute osmotic and ischemic stress in cortical slices and in vivo revealed by two-photon microscopy. Glia 2009, 57, 207–221. [Google Scholar] [CrossRef] [PubMed]
  9. Verkhratsky, A.; Butt, A.M. Glial Physiology and Pathophysiology; Wiley-Blackwell: Chichester, UK, 2013; p. 560. [Google Scholar]
  10. Pekny, M.; Pekna, M. Astrocyte reactivity and reactive astrogliosis: Costs and benefits. Physiol. Rev. 2014, 94, 1077–1098. [Google Scholar] [CrossRef] [PubMed]
  11. Nedergaard, M.; Ransom, B.; Goldman, S. New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci. 2003, 26, 523–530. [Google Scholar] [CrossRef] [PubMed]
  12. Stevens, B. Neuron-astrocyte signaling in the development and plasticity of neural circuits. Neurosignals 2008, 16, 278–288. [Google Scholar] [CrossRef] [PubMed]
  13. Haydon, P. Glia: Listening and talking to the synapse. Nat. Rev. Neurosci. 2001, 2, 185–193. [Google Scholar] [CrossRef] [PubMed]
  14. Anderson, C.; Nedergaard, M. Astrocyte-mediated control of cerebral microcirculation. Trends Neurosci. 2003, 26, 340–344. [Google Scholar] [CrossRef]
  15. Zonta, M.; Angulo, M.; Gobbo, S.; Rosengarten, B.; Hossmann, K.; Pozzan, T.; Carmignoto, G. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 2003, 6, 43–50. [Google Scholar] [CrossRef] [PubMed]
  16. Gordon, G.; Mulligan, S.; MacVicar, B. Astrocyte control of the cerebrovasculature. Glia 2007, 55, 1214–1221. [Google Scholar] [CrossRef] [PubMed]
  17. Dong, Y.; Benveniste, E. Immune function of astrocytes. Glia 2001, 36, 180–190. [Google Scholar] [CrossRef] [PubMed]
  18. De Keyser, J.; Zeinstra, E.; Frohman, E. Are astrocytes central players in the pathophysiology of multiple sclerosis? Arch. Neurol. 2003, 60, 132–136. [Google Scholar] [CrossRef] [PubMed]
  19. Abbott, N.; Rönnbäck, L.; Hansson, E. Astrocyte–endothelial interactions at the blood–brain barrier. Nat. Rev. Neurosci. 2006, 7, 41–53. [Google Scholar] [CrossRef] [PubMed]
  20. Ke, C.; Poon, W.S.; Ng, H.K.; Pang, J.C.; Chan, Y. Heterogeneous responses of aquaporin-4 in oedema formation in a replicated severe traumatic brain injury model in rats. Neurosci. Lett. 2001, 301, 21–24. [Google Scholar] [CrossRef]
  21. Nase, G.; Helm, P.J.; Enger, R.; Ottersen, O.P. Water entry into astrocytes during brain edema formation. Glia 2008, 56, 895–902. [Google Scholar] [CrossRef] [PubMed]
  22. Nedergaard, M.; Verkhratsky, A. Artifact versus reality—How astrocytes contribute to synaptic events. Glia 2012, 60, 1013–1023. [Google Scholar] [CrossRef] [PubMed]
  23. Verkhratsky, A.; Nedergaard, M. Astroglial cradle in the life of the synapse. Philos. Trans. R Soc. Lond. B 2014, 369, 20130595. [Google Scholar] [CrossRef] [PubMed]
  24. Parpura, V.; Zorec, R. Gliotransmission: Exocytotic release from astrocytes. Brain Res. Rev. 2010, 63, 83–92. [Google Scholar] [CrossRef] [PubMed]
  25. Osborne, K.D.; Lee, W.; Malarkey, E.B.; Irving, A.J.; Parpura, V. Dynamic imaging of cannabinoid receptor 1 vesicular trafficking in cultured astrocytes. ASN Neuro 2009, 1. [Google Scholar] [CrossRef] [PubMed]
  26. Kreft, M.; Stenovec, M.; Rupnik, M.; Grilc, S.; Krzan, M.; Potokar, M.; Pangrsic, T.; Haydon, P.; Zorec, R. Properties of Ca2+-dependent exocytosis in cultured astrocytes. Glia 2004, 46, 437–445. [Google Scholar] [CrossRef] [PubMed]
  27. Zorec, R.; Araque, A.; Carmignoto, G.; Haydon, P.G.; Verkhratsky, A.; Parpura, V. Astroglial excitability and gliotransmission: An appraisal of Ca2+ as a signalling route. ASN Neuro 2012, 4. [Google Scholar] [CrossRef] [PubMed]
  28. Parpura, V.; Heneka, M.T.; Montana, V.; Oliet, S.H.; Schousboe, A.; Haydon, P.G.; Stout, R.F.; Spray, D.C.; Reichenbach, A.; Pannicke, T.; et al. Glial cells in (patho)physiology. J. Neurochem. 2012, 121, 4–27. [Google Scholar] [CrossRef] [PubMed]
  29. Parpura, V.; Grubišić, V.; Verkhratsky, A. Ca2+ sources for the exocytotic release of glutamate from astrocytes. Biochim. Biophys. Acta 2011, 1813, 984–991. [Google Scholar] [CrossRef] [PubMed]
  30. Gucek, A.; Vardjan, N.; Zorec, R. Exocytosis in astrocytes: Transmitter release and membrane signal regulation. Neurochem. Res. 2012, 37, 2351–2363. [Google Scholar] [CrossRef] [PubMed]
  31. Potokar, M.; Kreft, M.; Pangrsic, T.; Zorec, R. Vesicle mobility studied in cultured astrocytes. Biochem. Biophys. Res. Commun. 2005, 329, 678–683. [Google Scholar] [CrossRef] [PubMed]
  32. Potokar, M.; Kreft, M.; Li, L.; Daniel Andersson, J.; Pangrsic, T.; Chowdhury, H.; Pekny, M.; Zorec, R. Cytoskeleton and vesicle mobility in astrocytes. Traffic 2007, 8, 12–20. [Google Scholar] [CrossRef] [PubMed]
  33. Vardjan, N.; Verkhratsky, A.; Zorec, R. Pathologic potential of astrocytic vesicle traffic: New targets to treat neurologic diseases? Cell Transplant. 2015, 24, 599–612. [Google Scholar] [CrossRef] [PubMed]
  34. Potokar, M.; Vardjan, N.; Stenovec, M.; Gabrijel, M.; Trkov, S.; Jorgačevski, J.; Kreft, M.; Zorec, R. Astrocytic vesicle mobility in health and disease. Int. J. Mol. Sci. 2013, 14, 11238–11258. [Google Scholar] [CrossRef] [PubMed]
  35. Azevedo, F.A.; Carvalho, L.R.; Grinberg, L.T.; Farfel, J.M.; Ferretti, R.E.; Leite, R.E.; Jacob Filho, W.; Lent, R.; Herculano-Houzel, S. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J. Comp. Neurol. 2009, 513, 532–541. [Google Scholar] [CrossRef] [PubMed]
  36. Bushong, E.A.; Martone, M.E.; Jones, Y.Z.; Ellisman, M.H. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J. Neurosci. 2002, 22, 183–192. [Google Scholar] [PubMed]
  37. Halassa, M.M.; Fellin, T.; Haydon, P.G. The tripartite synapse: Roles for gliotransmission in health and disease. Trends Mol. Med. 2007, 13, 54–63. [Google Scholar] [CrossRef] [PubMed]
  38. Agre, P.; Preston, G.M.; Smith, B.L.; Jung, J.S.; Raina, S.; Moon, C.; Guggino, W.B.; Nielsen, S. Aquaporin CHIP: The archetypal molecular water channel. Am. J. Physiol. 1993, 265, F463–F476. [Google Scholar] [PubMed]
  39. Nagelhus, E.A.; Ottersen, O.P. Physiological roles of aquaporin-4 in brain. Physiol. Rev. 2013, 93, 1543–1562. [Google Scholar] [CrossRef] [PubMed]
  40. Nielsen, S.; Nagelhus, E.A.; Amiry-Moghaddam, M.; Bourque, C.; Agre, P.; Ottersen, O.P. Specialized membrane domains for water transport in glial cells: High-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J. Neurosci. 1997, 17, 171–180. [Google Scholar] [PubMed]
  41. Agre, P.; Bonhivers, M.; Borgnia, M.J. The aquaporins, blueprints for cellular plumbing systems. J. Biol. Chem. 1998, 273, 14659–14662. [Google Scholar] [CrossRef] [PubMed]
  42. Jung, J.S.; Bhat, R.V.; Preston, G.M.; Guggino, W.B.; Baraban, J.M.; Agre, P. Molecular characterization of an aquaporin cDNA from brain: Candidate osmoreceptor and regulator of water balance. Proc. Natl. Acad. Sci. USA 1994, 91, 13052–13056. [Google Scholar] [CrossRef] [PubMed]
  43. Mulders, S.M.; Preston, G.M.; Deen, P.M.; Guggino, W.B.; van Os, C.H.; Agre, P. Water channel properties of major intrinsic protein of lens. J. Biol. Chem. 1995, 270, 9010–9016. [Google Scholar] [CrossRef] [PubMed]
  44. Mulders, S.M.; van der Kemp, A.J.; Terlouw, S.A.; van Boxtel, H.A.; van Os, C.H.; Deen, P.M. The exchange of functional domains among aquaporins with different transport characteristics. Pflugers. Arch. 1998, 436, 599–607. [Google Scholar] [CrossRef] [PubMed]
  45. Badaut, J.; Fukuda, A.M.; Jullienne, A.; Petry, K.G. Aquaporin and brain diseases. Biochim. Biophys. Acta 2014, 1840, 1554–1565. [Google Scholar] [CrossRef] [PubMed]
  46. Bondy, C.; Chin, E.; Smith, B.L.; Preston, G.M.; Agre, P. Developmental gene expression and tissue distribution of the CHIP28 water-channel protein. Proc. Natl. Acad. Sci. USA 1993, 90, 4500–4504. [Google Scholar] [CrossRef] [PubMed]
  47. Satoh, J.; Tabunoki, H.; Yamamura, T.; Arima, K.; Konno, H. Human astrocytes express aquaporin-1 and aquaporin-4 in vitro and in vivo. Neuropathology 2007, 27, 245–256. [Google Scholar] [CrossRef] [PubMed]
  48. Badaut, J.; Hirt, L.; Granziera, C.; Bogousslavsky, J.; Magistretti, P.J.; Regli, L. Astrocyte-specific expression of aquaporin-9 in mouse brain is increased after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2001, 21, 477–482. [Google Scholar] [CrossRef] [PubMed]
  49. Badaut, J.; Petit, J.M.; Brunet, J.F.; Magistretti, P.J.; Charriaut-Marlangue, C.; Regli, L. Distribution of aquaporin 9 in the adult rat brain: Preferential expression in catecholaminergic neurons and in glial cells. Neuroscience 2004, 128, 27–38. [Google Scholar] [CrossRef] [PubMed]
  50. Elkjaer, M.; Vajda, Z.; Nejsum, L.N.; Kwon, T.; Jensen, U.B.; Amiry-Moghaddam, M.; Frøkiaer, J.; Nielsen, S. Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain. Biochem. Biophys. Res. Commun. 2000, 276, 1118–1128. [Google Scholar] [CrossRef] [PubMed]
  51. Oshio, K.; Watanabe, H.; Song, Y.; Verkman, A.S.; Manley, G.T. Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel aquaporin-1. FASEB J. 2005, 19, 76–78. [Google Scholar] [CrossRef] [PubMed]
  52. Agre, P.; Brown, D.; Nielsen, S. Aquaporin water channels: Unanswered questions and unresolved controversies. Curr. Opin. Cell Biol. 1995, 7, 472–483. [Google Scholar] [CrossRef]
  53. Preston, G.M.; Agre, P. Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: Member of an ancient channel family. Proc. Natl. Acad. Sci. USA 1991, 88, 11110–11114. [Google Scholar] [CrossRef] [PubMed]
  54. Van Hoek, A.N.; Verkman, A.S. Functional reconstitution of the isolated erythrocyte water channel CHIP28. J. Biol. Chem. 1992, 267, 18267–18269. [Google Scholar] [PubMed]
  55. Nielsen, S.; Smith, B.L.; Christensen, E.I.; Agre, P. Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia. Proc. Natl. Acad. Sci. USA 1993, 90, 7275–7279. [Google Scholar] [CrossRef] [PubMed]
  56. Anthony, T.L.; Brooks, H.L.; Boassa, D.; Leonov, S.; Yanochko, G.M.; Regan, J.W.; Yool, A.J. Cloned human aquaporin-1 is a cyclic GMP-gated ion channel. Mol. Pharmacol. 2000, 57, 576–588. [Google Scholar] [PubMed]
  57. Boassa, D.; Stamer, W.D.; Yool, A.J. Ion channel function of aquaporin-1 natively expressed in choroid plexus. J. Neurosci. 2006, 26, 7811–7819. [Google Scholar] [CrossRef] [PubMed]
  58. Saparov, S.M.; Kozono, D.; Rothe, U.; Agre, P.; Pohl, P. Water and ion permeation of aquaporin-1 in planar lipid bilayers. Major differences in structural determinants and stoichiometry. J. Biol. Chem. 2001, 276, 31515–31520. [Google Scholar] [CrossRef] [PubMed]
  59. Hasegawa, H.; Lian, S.C.; Finkbeiner, W.E.; Verkman, A.S. Extrarenal tissue distribution of CHIP28 water channels by in situ hybridization and antibody staining. Am. J. Physiol. 1994, 266, C893–C903. [Google Scholar] [PubMed]
  60. Nandasena, B.G.; Suzuki, A.; Aita, M.; Kawano, Y.; Nozawa-Inoue, K.; Maeda, T. Immunolocalization of aquaporin-1 in the mechanoreceptive Ruffini endings in the periodontal ligament. Brain Res. 2007, 1157, 32–40. [Google Scholar] [PubMed]
  61. Oshio, K.; Watanabe, H.; Yan, D.; Verkman, A.S.; Manley, G.T. Impaired pain sensation in mice lacking Aquaporin-1 water channels. Biochem. Biophys. Res. Commun. 2006, 341, 1022–1028. [Google Scholar] [CrossRef] [PubMed]
  62. Misawa, T.; Arima, K.; Mizusawa, H.; Satoh, J. Close association of water channel AQP1 with amyloid-β deposition in Alzheimer disease brains. Acta Neuropathol. 2008, 116, 247–260. [Google Scholar] [CrossRef] [PubMed]
  63. Arciénega, I.I.; Brunet, J.F.; Bloch, J.; Badaut, J. Cell locations for AQP1, AQP4 and 9 in the non-human primate brain. Neuroscience 2010, 167, 1103–1114. [Google Scholar] [CrossRef] [PubMed]
  64. Shanahan, C.M.; Connolly, D.L.; Tyson, K.L.; Cary, N.R.; Osbourn, J.K.; Agre, P.; Weissberg, P.L. Aquaporin-1 is expressed by vascular smooth muscle cells and mediates rapid water transport across vascular cell membranes. J. Vasc. Res. 1999, 36, 353–362. [Google Scholar] [CrossRef] [PubMed]
  65. Pérez, E.; Barrachina, M.; Rodríguez, A.; Torrejón-Escribano, B.; Boada, M.; Hernández, I.; Sánchez, M.; Ferrer, I. Aquaporin expression in the cerebral cortex is increased at early stages of Alzheimer disease. Brain Res. 2007, 1128, 164–174. [Google Scholar] [CrossRef] [PubMed]
  66. Badaut, J.; Brunet, J.F.; Grollimund, L.; Hamou, M.F.; Magistretti, P.J.; Villemure, J.G.; Regli, L. Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. Acta Neurochir. Suppl. 2003, 86, 495–498. [Google Scholar] [PubMed]
  67. Costa, C.; Tortosa, R.; Rodríguez, A.; Ferrer, I.; Torres, J.M.; Bassols, A.; Pumarola, M. Aquaporin 1 and aquaporin 4 overexpression in bovine spongiform encephalopathy in a transgenic murine model and in cattle field cases. Brain Res. 2007, 1175, 96–106. [Google Scholar] [CrossRef] [PubMed]
  68. Kim, J.E.; Ryu, H.J.; Yeo, S.I.; Seo, C.H.; Lee, B.C.; Choi, I.G.; Kim, D.S.; Kang, T.C. Differential expressions of aquaporin subtypes in astroglia in the hippocampus of chronic epileptic rats. Neuroscience 2009, 163, 781–789. [Google Scholar] [CrossRef] [PubMed]
  69. Rodríguez, A.; Pérez-Gracia, E.; Espinosa, J.C.; Pumarola, M.; Torres, J.M.; Ferrer, I. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt–Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice. Acta Neuropathol. 2006, 112, 573–585. [Google Scholar] [CrossRef] [PubMed]
  70. Saadoun, S.; Papadopoulos, M.C.; Davies, D.C.; Bell, B.A.; Krishna, S. Increased aquaporin 1 water channel expression in human brain tumours. Br. J. Cancer 2002, 87, 621–623. [Google Scholar] [CrossRef] [PubMed]
  71. Nicchia, G.P.; Rossi, A.; Mola, M.G.; Procino, G.; Frigeri, A.; Svelto, M. Actin cytoskeleton remodeling governs aquaporin-4 localization in astrocytes. Glia 2008, 56, 1755–1766. [Google Scholar] [CrossRef] [PubMed]
  72. Potokar, M.; Stenovec, M.; Jorgačevski, J.; Holen, T.; Kreft, M.; Ottersen, O.P.; Zorec, R. Regulation of AQP4 surface expression via vesicle mobility in astrocytes. Glia 2013, 61, 917–928. [Google Scholar] [CrossRef] [PubMed]
  73. Zelenina, M. Regulation of brain aquaporins. Neurochem. Int. 2010, 57, 468–488. [Google Scholar] [CrossRef] [PubMed]
  74. Han, Z.; Patil, R.V. Protein kinase A-dependent phosphorylation of aquaporin-1. Biochem. Biophys. Res. Commun. 2000, 273, 328–332. [Google Scholar] [CrossRef] [PubMed]
  75. Zhang, W.; Zitron, E.; Hömme, M.; Kihm, L.; Morath, C.; Scherer, D.; Hegge, S.; Thomas, D.; Schmitt, C.P.; Zeier, M.; et al. Aquaporin-1 channel function is positively regulated by protein kinase C. J. Biol. Chem. 2007, 282, 20933–20940. [Google Scholar] [CrossRef] [PubMed]
  76. Yang, B.; Verkman, A.S. Water and glycerol permeabilities of aquaporins 1–5 and MIP determined quantitatively by expression of epitope-tagged constructs in Xenopus oocytes. J. Biol. Chem. 1997, 272, 16140–16146. [Google Scholar] [CrossRef] [PubMed]
  77. Patil, R.V.; Han, Z.; Wax, M.B. Regulation of water channel activity of aquaporin 1 by arginine vasopressin and atrial natriuretic peptide. Biochem. Biophys. Res. Commun. 1997, 238, 392–396. [Google Scholar] [CrossRef] [PubMed]
  78. Marinelli, R.A.; Tietz, P.S.; Pham, L.D.; Rueckert, L.; Agre, P.; LaRusso, N.F. Secretin induces the apical insertion of aquaporin-1 water channels in rat cholangiocytes. Am. J. Physiol. 1999, 276, G280–G286. [Google Scholar] [PubMed]
  79. Hasegawa, H.; Ma, T.; Skach, W.; Matthay, M.A.; Verkman, A.S. Molecular cloning of a mercurial-insensitive water channel expressed in selected water-transporting tissues. J. Biol. Chem. 1994, 269, 5497–5500. [Google Scholar] [PubMed]
  80. Frigeri, A.; Gropper, M.A.; Umenishi, F.; Kawashima, M.; Brown, D.; Verkman, A.S. Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J. Cell Sci. 1995, 108, 2993–3002. [Google Scholar] [PubMed]
  81. Frigeri, A.; Gropper, M.A.; Turck, C.W.; Verkman, A.S. Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc. Natl. Acad. Sci. USA 1995, 92, 4328–4331. [Google Scholar] [CrossRef] [PubMed]
  82. Nagelhus, E.A.; Veruki, M.L.; Torp, R.; Haug, F.M.; Laake, J.H.; Nielsen, S.; Agre, P.; Ottersen, O.P. Aquaporin-4 water channel protein in the rat retina and optic nerve: Polarized expression in Müller cells and fibrous astrocytes. J. Neurosci. 1998, 18, 2506–2519. [Google Scholar] [PubMed]
  83. Badaut, J.; Nehlig, A.; Verbavatz, J.; Stoeckel, M.; Freund-Mercier, M.J.; Lasbennes, F. Hypervascularization in the magnocellular nuclei of the rat hypothalamus: Relationship with the distribution of aquaporin-4 and markers of energy metabolism. J. Neuroendocrinol. 2000, 12, 960–969. [Google Scholar] [CrossRef] [PubMed]
  84. Badaut, J.; Verbavatz, J.M.; Freund-Mercier, M.J.; Lasbennes, F. Presence of aquaporin-4 and muscarinic receptors in astrocytes and ependymal cells in rat brain: A clue to a common function? Neurosci. Lett. 2000, 292, 75–78. [Google Scholar] [CrossRef]
  85. Rash, J.E.; Yasumura, T.; Hudson, C.S.; Agre, P.; Nielsen, S. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc. Natl. Acad. Sci. USA 1998, 95, 11981–11986. [Google Scholar] [CrossRef] [PubMed]
  86. Hirt, B.; Gleiser, C.; Eckhard, A.; Mack, A.F.; Müller, M.; Wolburg, H.; Löwenheim, H. All functional aquaporin-4 isoforms are expressed in the rat cochlea and contribute to the formation of orthogonal arrays of particles. Neuroscience 2011, 189, 79–92. [Google Scholar] [CrossRef] [PubMed]
  87. Takumi, Y.; Nagelhus, E.A.; Eidet, J.; Matsubara, A.; Usami, S.; Shinkawa, H.; Nielsen, S.; Ottersen, O.P. Select types of supporting cell in the inner ear express aquaporin-4 water channel protein. Eur. J. Neurosci. 1998, 10, 3584–3595. [Google Scholar] [CrossRef] [PubMed]
  88. Frigeri, A.; Nicchia, G.P.; Verbavatz, J.M.; Valenti, G.; Svelto, M. Expression of aquaporin-4 in fast-twitch fibers of mammalian skeletal muscle. J. Clin. Investig. 1998, 102, 695–703. [Google Scholar] [CrossRef] [PubMed]
  89. Moe, S.E.; Sorbo, J.G.; Sogaard, R.; Zeuthen, T.; Petter Ottersen, O.; Holen, T. New isoforms of rat aquaporin-4. Genomics 2008, 91, 367–377. [Google Scholar] [CrossRef] [PubMed]
  90. Neely, J.D.; Christensen, B.M.; Nielsen, S.; Agre, P. Heterotetrameric composition of aquaporin-4 water channels. Biochemistry 1999, 38, 11156–11163. [Google Scholar] [CrossRef] [PubMed]
  91. De Bellis, M.; Pisani, F.; Mola, M.G.; Basco, D.; Catalano, F.; Nicchia, G.P.; Svelto, M.; Frigeri, A. A novel human aquaporin-4 splice variant exhibits a dominant-negative activity: A new mechanism to regulate water permeability. Mol. Biol. Cell 2014, 25, 470–480. [Google Scholar] [CrossRef] [PubMed]
  92. Lu, M.; Lee, M.D.; Smith, B.L.; Jung, J.S.; Agre, P.; Verdijk, M.A.; Merkx, G.; Rijss, J.P.; Deen, P.M. The human AQP4 gene: Definition of the locus encoding two water channel polypeptides in brain. Proc. Natl. Acad. Sci. USA 1996, 93, 10908–10912. [Google Scholar] [CrossRef] [PubMed]
  93. Yang, B.; Ma, T.; Verkman, A.S. cDNA cloning, gene organization, and chromosomal localization of a human mercurial insensitive water channel. Evidence for distinct transcriptional units. J. Biol. Chem. 1995, 270, 22907–22913. [Google Scholar] [CrossRef] [PubMed]
  94. Furman, C.S.; Gorelick-Feldman, D.A.; Davidson, K.G.; Yasumura, T.; Neely, J.D.; Agre, P.; Rash, J.E. Aquaporin-4 square array assembly: Opposing actions of M1 and M23 isoforms. Proc. Natl. Acad. Sci. USA 2003, 100, 13609–13614. [Google Scholar] [CrossRef] [PubMed]
  95. Crane, J.M.; van Hoek, A.N.; Skach, W.R.; Verkman, A.S. Aquaporin-4 dynamics in orthogonal arrays in live cells visualized by quantum dot single particle tracking. Mol. Biol. Cell 2008, 19, 3369–3378. [Google Scholar] [CrossRef] [PubMed]
  96. Rossi, A.; Crane, J.M.; Verkman, A.S. Aquaporin-4 Mz isoform: Brain expression, supramolecular assembly and neuromyelitis optica antibody binding. Glia 2011, 59, 1056–1063. [Google Scholar] [CrossRef] [PubMed]
  97. Sørbø, J.G.; Fleckenstein, B.; Ottersen, O.P.; Holen, T. Small-scale purification and mass spectrometry analysis reveal a third aquaporin-4 protein isoform of 36 kDa in rat brain. J. Neurosci. Methods 2012, 211, 31–39. [Google Scholar] [CrossRef] [PubMed]
  98. Sorbo, J.G.; Moe, S.E.; Ottersen, O.P.; Holen, T. The molecular composition of square arrays. Biochemistry 2008, 47, 2631–2637. [Google Scholar] [CrossRef] [PubMed]
  99. Madrid, R.; Le Maout, S.; Barrault, M.B.; Janvier, K.; Benichou, S.; Mérot, J. Polarized trafficking and surface expression of the AQP4 water channel are coordinated by serial and regulated interactions with different clathrin-adaptor complexes. EMBO J. 2001, 20, 7008–7021. [Google Scholar] [CrossRef] [PubMed]
  100. Hub, J.S.; de Groot, B.L.; Grubmüller, H.; Groenhof, G. Quantifying artifacts in Ewald simulations of inhomogeneous systems with a net charge. J. Chem. Theory Comput. 2014, 10, 381–390. [Google Scholar] [CrossRef] [PubMed]
  101. Cheng, A.; van Hoek, A.N.; Yeager, M.; Verkman, A.S.; Mitra, A.K. Three-dimensional organization of a human water channel. Nature 1997, 387, 627–630. [Google Scholar] [PubMed]
  102. Marples, D.; Schroer, T.A.; Ahrens, N.; Taylor, A.; Knepper, M.A.; Nielsen, S. Dynein and dynactin colocalize with AQP2 water channels in intracellular vesicles from kidney collecting duct. Am. J. Physiol. 1998, 274, F384–F394. [Google Scholar] [PubMed]
  103. King, L.S.; Kozono, D.; Agre, P. From structure to disease: The evolving tale of aquaporin biology. Nat. Rev. Mol. Cell Biol. 2004, 5, 687–698. [Google Scholar] [CrossRef] [PubMed]
  104. Yasui, M.; Kwon, T.H.; Knepper, M.A.; Nielsen, S.; Agre, P. Aquaporin-6: An intracellular vesicle water channel protein in renal epithelia. Proc. Natl. Acad. Sci. USA 1999, 96, 5808–5813. [Google Scholar] [CrossRef] [PubMed]
  105. Yasui, M.; Hazama, A.; Kwon, T.H.; Nielsen, S.; Guggino, W.B.; Agre, P. Rapid gating and anion permeability of an intracellular aquaporin. Nature 1999, 402, 184–187. [Google Scholar] [PubMed]
  106. Gorelick, D.A.; Praetorius, J.; Tsunenari, T.; Nielsen, S.; Agre, P. Aquaporin-11: A channel protein lacking apparent transport function expressed in brain. BMC Biochem. 2006, 7, 14. [Google Scholar] [CrossRef] [PubMed]
  107. Takahashi, S.; Muta, K.; Sonoda, H.; Kato, A.; Abdeen, A.; Ikeda, M. The role of cysteine 227 in subcellular localization, water permeability, and multimerization of aquaporin-11. FEBS Open Bio 2014, 4, 315–320. [Google Scholar] [CrossRef] [PubMed]
  108. Hiroaki, Y.; Tani, K.; Kamegawa, A.; Gyobu, N.; Nishikawa, K.; Suzuki, H.; Walz, T.; Sasaki, S.; Mitsuoka, K.; Kimura, K.; et al. Implications of the aquaporin-4 structure on array formation and cell adhesion. J. Mol. Biol. 2006, 355, 628–639. [Google Scholar] [CrossRef] [PubMed]
  109. Verbavatz, J.M.; Ma, T.; Gobin, R.; Verkman, A.S. Absence of orthogonal arrays in kidney, brain and muscle from transgenic knockout mice lacking water channel aquaporin-4. J. Cell Sci. 1997, 110, 2855–2860. [Google Scholar] [PubMed]
  110. Rash, J.E.; Davidson, K.G.; Yasumura, T.; Furman, C.S. Freeze-fracture and immunogold analysis of aquaporin-4 (AQP4) square arrays, with models of AQP4 lattice assembly. Neuroscience 2004, 129, 915–934. [Google Scholar] [CrossRef] [PubMed]
  111. Tajima, M.; Crane, J.M.; Verkman, A.S. Aquaporin-4 (AQP4) associations and array dynamics probed by photobleaching and single-molecule analysis of green fluorescent protein-AQP4 chimeras. J. Biol. Chem. 2010, 285, 8163–8170. [Google Scholar] [CrossRef] [PubMed]
  112. Crane, J.M.; Bennett, J.L.; Verkman, A.S. Live cell analysis of aquaporin-4 M1/M23 interactions and regulated orthogonal array assembly in glial cells. J. Biol. Chem. 2009, 284, 35850–35860. [Google Scholar] [CrossRef] [PubMed]
  113. Crane, J.M.; Verkman, A.S. Determinants of aquaporin-4 assembly in orthogonal arrays revealed by live-cell single-molecule fluorescence imaging. J. Cell Sci. 2009, 122, 813–821. [Google Scholar] [CrossRef] [PubMed]
  114. Iliff, J.J.; Wang, M.; Liao, Y.; Plogg, B.A.; Peng, W.; Gundersen, G.A.; Benveniste, H.; Vates, G.E.; Deane, R.; Goldman, S.A.; et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med. 2012, 4, 147ra111. [Google Scholar] [CrossRef] [PubMed]
  115. Silberstein, C.; Bouley, R.; Huang, Y.; Fang, P.; Pastor-Soler, N.; Brown, D.; van Hoek, A.N. Membrane organization and function of M1 and M23 isoforms of aquaporin-4 in epithelial cells. Am. J. Physiol. Ren. Physiol. 2004, 287, F501–F511. [Google Scholar] [CrossRef] [PubMed]
  116. Yamamoto, N.; Sobue, K.; Fujita, M.; Katsuya, H.; Asai, K. Differential regulation of aquaporin-5 and -9 expression in astrocytes by protein kinase A. Brain Res. Mol. Brain Res. 2002, 104, 96–102. [Google Scholar] [CrossRef]
  117. Assentoft, M.; Kaptan, S.; Fenton, R.A.; Hua, S.Z.; de Groot, B.L.; MacAulay, N. Phosphorylation of rat aquaporin-4 at Ser111 is not required for channel gating. Glia 2013, 61, 1101–1112. [Google Scholar] [CrossRef] [PubMed]
  118. McCoy, E.S.; Haas, B.R.; Sontheimer, H. Water permeability through aquaporin-4 is regulated by protein kinase C and becomes rate-limiting for glioma invasion. Neuroscience 2010, 168, 971–981. [Google Scholar] [CrossRef] [PubMed]
  119. Yamamoto, N.; Sobue, K.; Miyachi, T.; Inagaki, M.; Miura, Y.; Katsuya, H.; Asai, K. Differential regulation of aquaporin expression in astrocytes by protein kinase C. Brain Res. Mol. Brain Res. 2001, 95, 110–116. [Google Scholar] [CrossRef]
  120. Stenovec, M.; Trkov, S.; Lasič, E.; Terzieva, S.; Kreft, M.; Rodríguez Arellano, J.J.; Parpura, V.; Verkhratsky, A.; Zorec, R. Expression of familial Alzheimer disease presenilin 1 gene attenuates vesicle traffic and reduces peptide secretion in cultured astrocytes devoid of pathologic tissue environment. Glia 2016, 64, 317–329. [Google Scholar] [CrossRef] [PubMed]
  121. Rossi, A.; Baumgart, F.; van Hoek, A.N.; Verkman, A.S. Post-Golgi supramolecular assembly of aquaporin-4 in orthogonal arrays. Traffic 2012, 13, 43–53. [Google Scholar] [CrossRef] [PubMed]
  122. Rossi, A.; Moritz, T.J.; Ratelade, J.; Verkman, A.S. Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes. J. Cell Sci. 2012, 125, 4405–4412. [Google Scholar] [CrossRef] [PubMed]
  123. Pisani, F.; Rossi, A.; Nicchia, G.P.; Svelto, M.; Frigeri, A. Translational regulation mechanisms of aquaporin-4 supramolecular organization in astrocytes. Glia 2011, 59, 1923–1932. [Google Scholar] [CrossRef] [PubMed]
  124. Suzuki, H.; Nishikawa, K.; Hiroaki, Y.; Fujiyoshi, Y. Formation of aquaporin-4 arrays is inhibited by palmitoylation of N-terminal cysteine residues. Biochim. Biophys. Acta 2008, 1778, 1181–1189. [Google Scholar] [CrossRef] [PubMed]
  125. Eid, T.; Lee, T.S.; Thomas, M.J.; Amiry-Moghaddam, M.; Bjørnsen, L.P.; Spencer, D.D.; Agre, P.; Ottersen, O.P.; de Lanerolle, N.C. Loss of perivascular aquaporin 4 may underlie deficient water and K+ homeostasis in the human epileptogenic hippocampus. Proc. Natl. Acad. Sci. USA 2005, 102, 1193–1198. [Google Scholar] [CrossRef] [PubMed]
  126. Lee, T.S.; Eid, T.; Mane, S.; Kim, J.H.; Spencer, D.D.; Ottersen, O.P.; de Lanerolle, N.C. Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy. Acta Neuropathol. 2004, 108, 493–502. [Google Scholar] [CrossRef] [PubMed]
  127. Moftakhar, P.; Lynch, M.D.; Pomakian, J.L.; Vinters, H.V. Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 2010, 69, 1201–1209. [Google Scholar] [CrossRef] [PubMed]
  128. Hoshi, A.; Yamamoto, T.; Shimizu, K.; Ugawa, Y.; Nishizawa, M.; Takahashi, H.; Kakita, A. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2012, 71, 750–759. [Google Scholar] [CrossRef] [PubMed]
  129. Yang, J.; Lunde, L.K.; Nuntagij, P.; Oguchi, T.; Camassa, L.M.; Nilsson, L.N.; Lannfelt, L.; Xu, Y.; Amiry-Moghaddam, M.; Ottersen, O.P.; et al. Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer’s disease. J. Alzheimers Dis. 2011, 27, 711–722. [Google Scholar] [PubMed]
  130. Aoki-Yoshino, K.; Uchihara, T.; Duyckaerts, C.; Nakamura, A.; Hauw, J.J.; Wakayama, Y. Enhanced expression of aquaporin 4 in human brain with inflammatory diseases. Acta Neuropathol. 2005, 110, 281–288. [Google Scholar] [CrossRef] [PubMed]
  131. Saadoun, S.; Papadopoulos, M.C.; Davies, D.C.; Krishna, S.; Bell, B.A. Aquaporin-4 expression is increased in oedematous human brain tumours. J. Neurol. Neurosurg. Psychiatry 2002, 72, 262–265. [Google Scholar] [CrossRef] [PubMed]
  132. Aoki, K.; Uchihara, T.; Tsuchiya, K.; Nakamura, A.; Ikeda, K.; Wakayama, Y. Enhanced expression of aquaporin 4 in human brain with infarction. Acta Neuropathol. 2003, 106, 121–124. [Google Scholar] [CrossRef] [PubMed]
  133. Tsukaguchi, H.; Shayakul, C.; Berger, U.V.; Mackenzie, B.; Devidas, S.; Guggino, W.B.; van Hoek, A.N.; Hediger, M.A. Molecular characterization of a broad selectivity neutral solute channel. J. Biol. Chem. 1998, 273, 24737–24743. [Google Scholar] [CrossRef] [PubMed]
  134. Tsukaguchi, H.; Weremowicz, S.; Morton, C.C.; Hediger, M.A. Functional and molecular characterization of the human neutral solute channel aquaporin-9. Am. J. Physiol. 1999, 277, F685–F696. [Google Scholar] [PubMed]
  135. Ishibashi, K.; Kuwahara, M.; Gu, Y.; Tanaka, Y.; Marumo, F.; Sasaki, S. Cloning and functional expression of a new aquaporin (AQP9) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol. Biochem. Biophys. Res. Commun. 1998, 244, 268–274. [Google Scholar] [CrossRef] [PubMed]
  136. Tan, G.; Sun, S.Q.; Yuan, D.L. Expression of the water channel protein aquaporin-9 in human astrocytic tumours: Correlation with pathological grade. J. Int. Med. Res. 2008, 36, 777–782. [Google Scholar] [CrossRef] [PubMed]
  137. Jelen, S.; Parm Ulhøi, B.; Larsen, A.; Frøkiær, J.; Nielsen, S.; Rützler, M. AQP9 expression in glioblastoma multiforme tumors is limited to a small population of astrocytic cells and CD15+/CalB+ leukocytes. PLoS ONE 2013, 8, e75764. [Google Scholar] [CrossRef] [PubMed]
  138. Oshio, K.; Binder, D.K.; Yang, B.; Schecter, S.; Verkman, A.S.; Manley, G.T. Expression of aquaporin water channels in mouse spinal cord. Neuroscience 2004, 127, 685–693. [Google Scholar] [CrossRef] [PubMed]
  139. Nicchia, G.P.; Frigeri, A.; Nico, B.; Ribatti, D.; Svelto, M. Tissue distribution and membrane localization of aquaporin-9 water channel: Evidence for sex-linked differences in liver. J. Histochem. Cytochem. 2001, 49, 1547–1556. [Google Scholar] [CrossRef] [PubMed]
  140. Amiry-Moghaddam, M.; Lindland, H.; Zelenin, S.; Roberg, B.A.; Gundersen, B.B.; Petersen, P.; Rinvik, E.; Torgner, I.A.; Ottersen, O.P. Brain mitochondria contain aquaporin water channels: Evidence for the expression of a short AQP9 isoform in the inner mitochondrial membrane. FASEB J. 2005, 19, 1459–1467. [Google Scholar] [CrossRef] [PubMed]
  141. Badaut, J.; Brunet, J.F.; Guérin, C.; Regli, L.; Pellerin, L. Alteration of glucose metabolism in cultured astrocytes after AQP9-small interference RNA application. Brain Res. 2012, 1473, 19–24. [Google Scholar] [CrossRef] [PubMed]
Ijms 17 01121 g001 1024
Figure 1. Aquaporin 4 (AQP4) isoforms differ in structure. (A) The proposed hourglass model of AQP4. Loops B and E contain NPA motifs (Asn-Pro-Ala), which form an aqueous pore in the membrane bilayer; and (B) schematic representations of the AQP4 channel and its isoforms. (i) AQP4a, AQP4c, and AQP4e have six bilayer-spanning domains (1–6) and five interconnecting loops (A–E); (ii) AQP4b, AQP4d, AQP4f isoforms lack helices 4 and 5 together with their interconnecting loop D; and (iii) AQP4-Δ isoform lacks the final part of helix 5 and loop E.
Figure 1. Aquaporin 4 (AQP4) isoforms differ in structure. (A) The proposed hourglass model of AQP4. Loops B and E contain NPA motifs (Asn-Pro-Ala), which form an aqueous pore in the membrane bilayer; and (B) schematic representations of the AQP4 channel and its isoforms. (i) AQP4a, AQP4c, and AQP4e have six bilayer-spanning domains (1–6) and five interconnecting loops (A–E); (ii) AQP4b, AQP4d, AQP4f isoforms lack helices 4 and 5 together with their interconnecting loop D; and (iii) AQP4-Δ isoform lacks the final part of helix 5 and loop E.
Ijms 17 01121 g001
Table
Table 1. Aquaporin (AQP) types in astrocytes.
Table 1. Aquaporin (AQP) types in astrocytes.
AQP TypeAQP IsoformsPermeability to WaterPermeability to Small Solutes (i.e., Glycerol, Urea, Monocarboxylates)Ability to Form OAPs in the Plasma Membrane
AQP1AQP1YesNoNo
AQP4AQP4a (M1)YesNoOnly together with AQP4c
AQP4c (M23)YesNoYes
AQP4eYesNoOnly together with AQP4c
AQP4b?NoN/A
AQP4d?NoN/A
AQP4f?NoN/A
AQP9AQP9 ~32 kDa (is AQP9 ~30 kDa its splicing isoform?)YesYesNo
AQP9 ~25 kDaYesYesNo
?, not yet definitely determined; N/A, not applicable; OAPs, orthogonal arrays of particles.
Table
Table 2. The expression of AQP1 in different cells.
Table 2. The expression of AQP1 in different cells.
Cell TypeReference
Erythrocytes[53]
Renal epithelial cells[53]
Endothelial cells (except central nervous system (CNS))[55]
Epithelial cells of the choroid plexus[55,59]
Epithelial cells of the iris, ciliary body, lens, trachea, kidney, colonic crypt, sweat glands, pancreatic acini, gallbladder epithelium, placental syncytial trophoblast cells[55,59]
Sensory nerve fibers in the dorsal horn of the spinal cord and the trigeminal sensory ganglia[60,61]
Reactive astrocytes (human CNS) in Alzheimer disease, Creutzfeldt–Jakob disease, multiple sclerosis, and in ischemic lesions[47,62]
Astrocytes (non-human primate CNS, a subpopulation of white matter astrocytes in Macaca fascicularis)[63]
Schwann cells (Macaca fascicularis CNS)[63]
Trigeminal nerve fibers (Macaca fascicularis CNS)[63]
Neurons on the surface of the pial blood vessels (Macaca fascicularis CNS)[63]
Vascular smooth muscle cells[64]
Table
Table 3. The expression of AQP4 in different cells.
Table 3. The expression of AQP4 in different cells.
Cell TypeReference
Astrocytes (brain and spinal cord)[42,79,80,85]
A subpopulation of brain ependymal cells[40,80,81,85]
Retina, iris, ciliary body[79,81,82]
Lung epithelial cells[79,81]
Renal basolateral plasma membrane of collecting duct principal cells, renal papillary vasa recta[79,81]
Colon (villus) epithelial cells[81]
Stomach parietal cells[80]
Excretory tubules of salivary and lacrimal glands[80]
Auditory epithelium of the organ of Corti[86,87]
Skeletal muscle; the sarcolemma of fast-twitch fibers[80,88]
Table
Table 4. AQP4 isoforms.
Table 4. AQP4 isoforms.
AQP4 IsoformsCell TypeIntracellular LocalizationReference
AQP4a (M1)AstrocytesPM[85,90,95]
AQP4c (M23)Astrocytes, skeletal muscle, kidneyPM[85,90,95]
AQP4e (Mz)Astrocytes (rat), organ of Corti (rat)PM, intracellular vesicles, GA, EC[72,89,96]
AQP4bAstrocytes (rat)GA[89]
AQP4dAstrocytes (rat)GA, EC[72,89]
AQP4fAstrocytes (rat)GA[89]
AQP4-ΔSkeletal muscleER, faintly in the PM[91]
PM, plasma membrane; ER, endoplasmic reticulum; EC, late endosomal compartments; GA, Golgi apparatus.
Table
Table 5. The expression of AQP9 in different cell types.
Table 5. The expression of AQP9 in different cell types.
Cell TypeReference
Spinal cord and brain:
Astrocytes, ependymal cells lining the ventricles and tanycytes, catecholaminergic neurons, endothelial cells of pial vessels, Bergmann glia		[49,50,138]
Hepatocytes[50,139]
Testis Leydig cells[50]
Epididymis stereocilia[50]
Spleen leukocytes[50]

Share and Cite

MDPI and ACS Style

Potokar, M.; Jorgačevski, J.; Zorec, R. Astrocyte Aquaporin Dynamics in Health and Disease. Int. J. Mol. Sci. 2016, 17, 1121. https://doi.org/10.3390/ijms17071121

AMA Style

Potokar M, Jorgačevski J, Zorec R. Astrocyte Aquaporin Dynamics in Health and Disease. International Journal of Molecular Sciences. 2016; 17(7):1121. https://doi.org/10.3390/ijms17071121

Chicago/Turabian Style

Potokar, Maja, Jernej Jorgačevski, and Robert Zorec. 2016. "Astrocyte Aquaporin Dynamics in Health and Disease" International Journal of Molecular Sciences 17, no. 7: 1121. https://doi.org/10.3390/ijms17071121

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop